Tazeen Ahmad
Stock Analyst at Bank of America Securities
(4.36)
# 1,220
Out of 4,442 analysts
964
Total ratings
57.9%
Success rate
5.7%
Average return
Main Sectors:
Stocks Rated by Tazeen Ahmad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Reiterated: Buy | $27 | $10.12 | +166.93% | 20 | Jun 22, 2026 | |
| TSHA Taysha Gene Therapies | Reiterated: Buy | $9 → $10 | $6.86 | +45.77% | 5 | Jun 22, 2026 | |
| IMMX Immix Biopharma | Initiated Coverage: Buy | $27 | $9.91 | +172.45% | 1 | Jun 18, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $288 | $238.59 | +20.71% | 69 | Jun 16, 2026 | |
| ARGX argenx SE | Maintained: Buy | $1,016 | $853.40 | +19.05% | 60 | Jun 16, 2026 | |
| INCY Incyte | Maintained: Buy | $124 | $104.40 | +18.77% | 53 | Jun 15, 2026 | |
| RYTM Rhythm Pharmaceuticals | Maintained: Buy | $149 | $106.19 | +40.31% | 42 | Jun 15, 2026 | |
| BLTE Belite Bio | Maintained: Buy | $200 | $145.09 | +37.85% | 4 | Jun 15, 2026 | |
| APGE Apogee Therapeutics | Maintained: Buy | $131 | $132.88 | -1.41% | 6 | Jun 11, 2026 | |
| KYMR Kymera Therapeutics | Reiterated: Buy | $110 | $98.25 | +11.96% | 15 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $162 | $125.05 | +29.55% | 9 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 → $3 | $3.85 | -22.08% | 23 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.00 | - | 4 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $90.62 | +37.94% | 53 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $24.77 | - | 20 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $2.2 | $2.16 | +1.85% | 12 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $29.19 | - | 13 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3 | $1.82 | +64.84% | 21 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $33 | $24.44 | +35.02% | 2 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $860 | $618.03 | +39.15% | 11 | May 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $18 → $4 | $4.23 | -5.44% | 2 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $82.13 | - | 49 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $31 → $33 | $33.19 | -0.57% | 18 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 | $9.55 | -16.23% | 16 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $51.27 | +13.13% | 10 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.28 | +51.52% | 22 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $22.60 | - | 45 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $304 → $307 | $347.01 | -11.53% | 4 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.31 | - | 35 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $28.73 | - | 46 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $288.18 | - | 45 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $161.44 | - | 46 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $598 | $468.42 | +27.66% | 23 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $8.14 | +71.99% | 22 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $19 | $17.26 | +10.08% | 69 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $812.00 | - | 6 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $1.61 | n/a | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $82 → $79 | $11.60 | n/a | 12 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2 → $1 | $1.15 | n/a | 8 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $2.10 | n/a | 3 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $6 | $4.36 | n/a | 7 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $23 | $305.37 | n/a | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $5 → $1 | $24.86 | n/a | 3 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $9 | $16.99 | n/a | 4 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $8 | $3.12 | n/a | 6 | Jul 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $150 | $61.00 | n/a | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $28 | $0.9682 | n/a | 1 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $1.83 | n/a | 1 | Mar 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 | $16.11 | n/a | 1 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 → $48 | $23.51 | n/a | 3 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $41 → $6 | $7.05 | n/a | 2 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $8.15 | n/a | 1 | Feb 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $2.15 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $0.6675 | n/a | 1 | Nov 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $79.85 | n/a | 1 | Jun 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $13 | $23.55 | n/a | 1 | Sep 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $51.21 | n/a | 1 | Sep 19, 2014 |
Ocular Therapeutix
Jun 22, 2026
Reiterated: Buy
Price Target: $27
Current: $10.12
Upside: +166.93%
Taysha Gene Therapies
Jun 22, 2026
Reiterated: Buy
Price Target: $9 → $10
Current: $6.86
Upside: +45.77%
Immix Biopharma
Jun 18, 2026
Initiated Coverage: Buy
Price Target: $27
Current: $9.91
Upside: +172.45%
Ascendis Pharma
Jun 16, 2026
Maintained: Buy
Price Target: $288
Current: $238.59
Upside: +20.71%
argenx SE
Jun 16, 2026
Maintained: Buy
Price Target: $1,016
Current: $853.40
Upside: +19.05%
Incyte
Jun 15, 2026
Maintained: Buy
Price Target: $124
Current: $104.40
Upside: +18.77%
Rhythm Pharmaceuticals
Jun 15, 2026
Maintained: Buy
Price Target: $149
Current: $106.19
Upside: +40.31%
Belite Bio
Jun 15, 2026
Maintained: Buy
Price Target: $200
Current: $145.09
Upside: +37.85%
Apogee Therapeutics
Jun 11, 2026
Maintained: Buy
Price Target: $131
Current: $132.88
Upside: -1.41%
Kymera Therapeutics
Jun 8, 2026
Reiterated: Buy
Price Target: $110
Current: $98.25
Upside: +11.96%
Jun 2, 2026
Maintained: Buy
Price Target: $162
Current: $125.05
Upside: +29.55%
Jun 2, 2026
Maintained: Sell
Price Target: $8 → $3
Current: $3.85
Upside: -22.08%
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $25.00
Upside: -
Jun 1, 2026
Maintained: Buy
Price Target: $125
Current: $90.62
Upside: +37.94%
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $24.77
Upside: -
May 21, 2026
Reiterated: Hold
Price Target: $2 → $2.2
Current: $2.16
Upside: +1.85%
May 21, 2026
Reiterated: Sell
Price Target: n/a
Current: $29.19
Upside: -
May 21, 2026
Reiterated: Sell
Price Target: $3
Current: $1.82
Upside: +64.84%
May 21, 2026
Reiterated: Buy
Price Target: $35 → $33
Current: $24.44
Upside: +35.02%
May 17, 2026
Maintained: Buy
Price Target: $860
Current: $618.03
Upside: +39.15%
May 15, 2026
Downgraded: Sell
Price Target: $18 → $4
Current: $4.23
Upside: -5.44%
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $82.13
Upside: -
May 14, 2026
Maintained: Hold
Price Target: $31 → $33
Current: $33.19
Upside: -0.57%
May 8, 2026
Reiterated: Sell
Price Target: $8
Current: $9.55
Upside: -16.23%
May 8, 2026
Reiterated: Buy
Price Target: $58
Current: $51.27
Upside: +13.13%
May 8, 2026
Reiterated: Buy
Price Target: $8
Current: $5.28
Upside: +51.52%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $22.60
Upside: -
May 1, 2026
Reiterated: Sell
Price Target: $304 → $307
Current: $347.01
Upside: -11.53%
Apr 16, 2026
Maintained: Buy
Price Target: n/a
Current: $9.31
Upside: -
Apr 16, 2026
Maintained: Buy
Price Target: n/a
Current: $28.73
Upside: -
Apr 15, 2026
Maintained: Buy
Price Target: n/a
Current: $288.18
Upside: -
Apr 15, 2026
Maintained: Buy
Price Target: n/a
Current: $161.44
Upside: -
Apr 15, 2026
Reiterated: Buy
Price Target: $598
Current: $468.42
Upside: +27.66%
Mar 18, 2026
Reiterated: Hold
Price Target: $14
Current: $8.14
Upside: +71.99%
Feb 25, 2026
Reiterated: Sell
Price Target: $19
Current: $17.26
Upside: +10.08%
Dec 18, 2025
Maintained: Buy
Price Target: n/a
Current: $812.00
Upside: -
Apr 1, 2025
Downgraded: Sell
Price Target: $1
Current: $1.61
Upside: n/a
Sep 19, 2024
Maintained: Buy
Price Target: $82 → $79
Current: $11.60
Upside: n/a
Oct 17, 2023
Maintained: Sell
Price Target: $2 → $1
Current: $1.15
Upside: n/a
May 24, 2023
Reiterated: Hold
Price Target: $4
Current: $2.10
Upside: n/a
Mar 27, 2023
Maintained: Sell
Price Target: $6
Current: $4.36
Upside: n/a
Mar 6, 2023
Reiterated: Hold
Price Target: $4.5 → $23
Current: $305.37
Upside: n/a
Nov 16, 2022
Downgraded: Sell
Price Target: $5 → $1
Current: $24.86
Upside: n/a
Apr 19, 2022
Maintained: Sell
Price Target: $10 → $9
Current: $16.99
Upside: n/a
Jul 21, 2021
Maintained: Buy
Price Target: $16 → $8
Current: $3.12
Upside: n/a
Jan 25, 2021
Reiterated: Hold
Price Target: $150
Current: $61.00
Upside: n/a
Jun 3, 2019
Initiated Coverage: Hold
Price Target: $28
Current: $0.9682
Upside: n/a
Mar 4, 2019
Initiated Coverage: Buy
Price Target: $26
Current: $1.83
Upside: n/a
Dec 20, 2018
Downgraded: Sell
Price Target: $8
Current: $16.11
Upside: n/a
Oct 10, 2018
Maintained: Hold
Price Target: $46 → $48
Current: $23.51
Upside: n/a
Aug 3, 2018
Downgraded: Sell
Price Target: $41 → $6
Current: $7.05
Upside: n/a
Feb 20, 2018
Initiated Coverage: Buy
Price Target: $23
Current: $8.15
Upside: n/a
Nov 27, 2017
Initiated Coverage: Hold
Price Target: $16
Current: $2.15
Upside: n/a
Nov 8, 2016
Reiterated: Sell
Price Target: $5
Current: $0.6675
Upside: n/a
Jun 2, 2016
Reiterated: Sell
Price Target: $5
Current: $79.85
Upside: n/a
Sep 9, 2015
Downgraded: Sell
Price Target: $13
Current: $23.55
Upside: n/a
Sep 19, 2014
Reiterated: Buy
Price Target: $110
Current: $51.21
Upside: n/a